Sectors
ANIK
Anika Therapeutics, Inc.
20.60
1 x 14.48
1 x 20.69
bid
ask
-
0.08
0.39%
09:40 AM
timesize
| Ytd | 114.36% | |
| 1y | 150.91% |
20.51
day range
20.65
8.15
52 week range
22.88
| Open | 20.59 | Prev Close | 20.68 | Low | 20.51 | High | 20.65 | Mkt Cap | 275.69M |
| Vol | 3.57K | Avg Vol | 82.30K | EPS | 0.49 | P/E | 42.04 | Forward P/E | -81.65 |
| Beta | 0.20 | Short Ratio | 2.43 | Inst. Own | 91.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 15.81 | 200-d Avg | 12.85 | 1yr Est | 26.50 |
| Income Statement | |||
| Total Revenue | 32.61M | ||
| Revenues (USD) | 32.61M | ||
| Cost of Revenue | 11.37M | ||
| Gross Profit | 21.24M | ||
| Operating Expenses | 18.29M | ||
| Research and Development Expense | 7.34M | ||
| Selling, General and Administrative Expense | 10.95M | ||
| Operating Income | 2.95M | ||
| Income Tax Expense | 71.00K | ||
| Net Income | 3.31M | ||
| Net Income Common Stock | 3.31M | ||
| Net Income Common Stock (USD) | 3.31M | ||
| Consolidated Income | 3.31M | ||
| Earnings per Basic Share | 0.25 | ||
| Earnings per Basic Share (USD) | 0.25 | ||
| Earnings per Diluted Share | 0.24 | ||
| Earning Before Interest & Taxes (EBIT) | 3.38M | ||
| Earning Before Interest & Taxes (USD) | 3.38M | ||
| Weighted Average Shares | 13.33M | ||
| Weighted Average Shares Diluted | 13.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 38.41M | ||
| Cash and Equivalents (USD) | 38.41M | ||
| Investments | 5.72M | ||
| Investments Non-Current | 5.72M | ||
| Trade and Non-Trade Receivables | 29.06M | ||
| Current Assets | 99.19M | ||
| Property, Plant & Equipment Net | 65.05M | ||
| Total Assets | 183.47M | ||
| Total Debt | 23.32M | ||
| Current Liabilities | 22.15M | ||
| Debt Non-Current | 23.32M | ||
| Total Liabilities | 46.19M | ||
| Accumulated Retained Earnings (Deficit) | 59.04M | ||
| Accumulated Other Comprehensive Income | -5.33M | ||
| Shareholders Equity | 137.28M | ||
| Shareholders Equity (USD) | 137.28M | ||
| Assets Non-Current | 84.28M | ||
| Total Debt (USD) | 23.32M | ||
| Goodwill and Intangible Assets | 9.48M | ||
| Inventory | 28.57M | ||
| Liabilities Non-Current | 24.05M | ||
| Trade and Non-Trade Payables | 6.24M | ||
| Tax Assets | 1.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.97M | ||
| Net Cash Flow from Financing | -701.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.61M | ||
| Capital Expenditure | -1.45M | ||
| Issuance (Purchase) of Equity Shares | -643.00K | ||
| Net Cash Flow from Investing | -1.28M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 169.00K | ||
| Net Cash Flow from Operations | -684.00K | ||
| Effect of Exchange Rate Changes on Cash | 57.00K | ||
| Share Based Compensation | 1.83M | ||